BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 12176517)

  • 1. A novel scale of immunosuppression exposure and correlation to outcomes after renal transplantation.
    Morrissey PE; Gohh RY; Monaco AP
    Transplant Proc; 2002 Aug; 34(5):1640-1. PubMed ID: 12176517
    [No Abstract]   [Full Text] [Related]  

  • 2. Results of renal transplantation of the Siriraj Hospital-Thailand.
    Vareesangthip K; Jitpraphai P; Vongwiwatana A; Permpikul P; Pornpong C; Larpkitkachorn R; Ong-Aj-Yooth L;
    Transplant Proc; 2003 Feb; 35(1):159-62. PubMed ID: 12591348
    [No Abstract]   [Full Text] [Related]  

  • 3. Immunosuppression strategies in developing countries.
    Naqvi SA
    Transplant Proc; 2002 Sep; 34(6):2083-4. PubMed ID: 12270322
    [No Abstract]   [Full Text] [Related]  

  • 4. Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients.
    Braun F; Schütz E; Peters B; Talaulicar R; Grupp C; Undre N; Schäfer A; Armstrong VW; Oellerich M; Ringe B
    Transplant Proc; 2001 May; 33(3):2127-8. PubMed ID: 11377473
    [No Abstract]   [Full Text] [Related]  

  • 5. Improved outcome of minor-mismatched living renal allografts under tacrolimus immunosuppression.
    Tanabe K; Ishida H; Tokumoto T; Shimmura H; Toda F; Omoto K; Makiyama K; Yagisawa T; Fuchinoue S; Teraoka S; Toma H
    Transplant Proc; 2002 Aug; 34(5):1668-70. PubMed ID: 12176528
    [No Abstract]   [Full Text] [Related]  

  • 6. Results of renal transplantation over 20 years after surgery, using azathioprine and low-dose prednisolone as the sole immunosuppression.
    Yoshimura N; Okamoto M; Akioka K; Nakamura K; Ushigome H; Kadotani Y; Nobori S; Higuchi A; Ohmori Y
    Transplant Proc; 2003 Feb; 35(1):143-4. PubMed ID: 12591340
    [No Abstract]   [Full Text] [Related]  

  • 7. Donor bone marrow, chimerism, histocompatibility and renal allograft rejection.
    Ciancio G; Garcia-Morales R; Burke GW; Roth D; Esquenazi V; Tzakis A; Miller J
    Transplant Proc; 1999; 31(1-2):679. PubMed ID: 10083291
    [No Abstract]   [Full Text] [Related]  

  • 8. Donor and recipient risk factors and choice of immunosuppression determine long-term outcome in renal transplantation.
    Mathew TH; McDonald SP; Russ GR
    Transplant Proc; 2001; 33(7-8):3400-2. PubMed ID: 11750455
    [No Abstract]   [Full Text] [Related]  

  • 9. Prolonged delayed graft function decreases graft survival in transplant patients taking cyclosporine.
    Fernández-Juarez G; Marcén R; Pascual J; Teruel JL; Rivera ME; Villafruela JJ; Mampaso F; Burgos FJ; Ortuño J
    Transplant Proc; 2002 Feb; 34(1):338-9. PubMed ID: 11959314
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of HLA semi-identical pretransplant blood transfusions on renal allograft outcome.
    Mariat C; Alamartine E; De Filippis JP; Deprele C; Le Petit JC; Goure D; Berthoux F
    Transplant Proc; 2000 Mar; 32(2):381-3. PubMed ID: 10715446
    [No Abstract]   [Full Text] [Related]  

  • 11. Emerging challenges in transplantation in developing countries.
    Rizvi SA; Naqvi SA; Hussain Z; Hashmi A; Akhtar F; Hussain M; Ahmed E; Zafar MN; Muzaffar R; Hafiz S
    Transplant Proc; 2002 Dec; 34(8):3146-9. PubMed ID: 12493403
    [No Abstract]   [Full Text] [Related]  

  • 12. Clinical immunosuppressive regimens and clinical results in renal transplantation.
    Bertolatus JA
    Semin Nephrol; 1992 Jul; 12(4):332-42. PubMed ID: 1410861
    [No Abstract]   [Full Text] [Related]  

  • 13. Non-heart-beating donor kidney transplantation under tacrolimus immunosuppression.
    Toda F; Tanabe K; Tokumoto T; Ishikawa N; Koga S; Ito S; Yagisawa T; Toma H
    Transplant Proc; 2000 Nov; 32(7):1726-9. PubMed ID: 11119909
    [No Abstract]   [Full Text] [Related]  

  • 14. Factors affecting the graft survival in cadaver donor kidney transplantation.
    Chon SE; Lee KW; Joh JW; Kim SJ; Park JH; Lee SK; Oh HY; Huh WS; Kim YI; Lee BB
    Transplant Proc; 2003 Feb; 35(1):147-8. PubMed ID: 12591342
    [No Abstract]   [Full Text] [Related]  

  • 15. Spouse donor kidney transplantation in Thailand.
    Jirasiritham S; Sumethkul V; Mavichak V; Danviriyasup K; Jirasiritham SI
    Transplant Proc; 2000 Nov; 32(7):1600-1. PubMed ID: 11119854
    [No Abstract]   [Full Text] [Related]  

  • 16. Primary tacrolimus immunosuppression in kidney recipients considered "higher immunologic risk".
    Braun F; Lorf T; Schütz E; Canelo R; Hanack U; Döpkens K; Sattler B; Grupp C; Ringe B
    Transplant Proc; 2000 Nov; 32(7):2535. PubMed ID: 11120281
    [No Abstract]   [Full Text] [Related]  

  • 17. Living unrelated kidney transplantation.
    Malaise J; Mourad M; Besse T; Jamar F; Baldi A; Setola P; De Meyer M; Pirson Y; Squifflet JP
    Transplant Proc; 1997 Nov; 29(7):2770-2. PubMed ID: 9365556
    [No Abstract]   [Full Text] [Related]  

  • 18. Factors influencing kidney graft survival in Latin America. Collaborative Transplant Study.
    Opelz G
    Transplant Proc; 1999 Nov; 31(7):2951-4. PubMed ID: 10578347
    [No Abstract]   [Full Text] [Related]  

  • 19. Prophylactic use of deoxyspergualin improves long-term graft survival in living related renal transplant recipients transfused with donor-specific blood.
    Amada N; Okazaki H; Sato T; Miura S; Ohashi Y
    Transplant Proc; 2001 May; 33(3):2256-7. PubMed ID: 11377520
    [No Abstract]   [Full Text] [Related]  

  • 20. Donor-specific blood transfusion in living-related renal transplantation: fourteen-year experience.
    Okazaki H; Sato T; Miura S; Amada N
    Transplant Proc; 1997; 29(1-2):200-2. PubMed ID: 9122962
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.